SUBSCRIBE
SUBSCRIBE
News   Business

Bentley Pharmaceuticals Reports $0.10 Diluted EPS on Record Revenues of $31.4 Million in the First Quarter of 2007

May 1, 2007 | 
1 min read

EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today reported financial results for the three months ended March 31, 2007.

Earnings
MORE ON THIS TOPIC
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel
Correct decision chosing - confused man character standing on the crossroads and looking at signpost with three different directions - conceptual vector illustration
Depression
Relmada Considering ‘Strategic Alternatives’ After Failure of Depression Asset
December 9, 2024
 · 
1 min read
 · 
Heather McKenzie
Pictured: Eli Lilly's biotechnology center in California
Manufacturing
Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac